Preferred labels and language to discuss low-risk lesions that may be cancer precursors: A review
Patient Education and Counseling · 2024
DOI: 10.1016/j.pec.2024.108321 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Patient Education and Counseling, 2024. Verfasst von Mavis S Lyons und 7 weiteren Autor:innen. Beteiligte Einrichtung: Toronto General Hospital Research Institute, University Health Network, Toronto, Canada. Hauptthemen laut MEDLINE: Physician-Patient Relations, Neoplasms, Language. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Cancer Society.
Abstract (Originalsprache)
OBJECTIVES: Patients diagnosed with low-risk lesions are confused about whether they have cancer, and experience similar anxiety to those with invasive cancer, which affects quality of life. Current labels for low-risk lesions were chosen by clinicians and lack meaning to patients. METHODS: We reviewed published research on preferred labels and language for low-risk lesions, and the rationale for those preferences. RESULTS: Of 6569 titles screened, we included 13 studies. Among healthy adults with cervix or prostate lesions, use of the term "cancer" rather than "nodule" or "lesion" resulted in greater anxiety, higher perceived disease severity, and selection of more invasive treatment. Physicians asked about removing "carcinoma" from thyroid lesion labels to reduce patient anxiety and discourage over-treatment did not support this change, instead preferring a term that included "neoplasm". CONCLUSIONS: This review revealed a startling paucity of research on preferences for low-risk lesion labels and language, and associated rationale. Future research is needed to understand how to improve communication about low-risk lesions. PRACTICE IMPLICATIONS: To reduce anxiety and improve the overall well-being of patients, it is crucial to gain a deeper understanding of how to improve patient-provider conversations regarding screen-detected lesions with a low risk of developing into invasive cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
- McGill University Health Centre, Montreal, Canada.
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
- Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
- Toronto General Hospital Research Institute, University Health Network, Toronto, Canada. Electronic address: anna.gagliardi@uhnresearch.ca.
Förderung
- Canadian Cancer Society
Zitieren
APA
Lyons, M. S., Dhakal, S., Baker, C., Chaput, G., Finelli, A., Kupets, R., Look Hong, N. J., & Gagliardi, A. R. (2024). Preferred labels and language to discuss low-risk lesions that may be cancer precursors: A review. Patient Education and Counseling. https://doi.org/10.1016/j.pec.2024.108321
Vancouver
Lyons MS, Dhakal S, Baker C, Chaput G, Finelli A, Kupets R, et al. Preferred labels and language to discuss low-risk lesions that may be cancer precursors: A review. Patient Education and Counseling. 2024. doi:10.1016/j.pec.2024.108321
BibTeX
@article{Lyons2024,
author = {Lyons, Mavis S and Dhakal, Smita and Baker, Clara and Chaput, Genevieve and Finelli, Antonio and Kupets, Rachel and Look Hong, Nicole J and Gagliardi, Anna R},
title = {Preferred labels and language to discuss low-risk lesions that may be cancer precursors: A review},
journal = {Patient Education and Counseling},
year = {2024},
doi = {10.1016/j.pec.2024.108321}
}
EUVIMED